Recent advancements regarding the field of diabetes treatment have brought about a novel class of medications known as GLP-1 and GIP receptor agonists. These agents offer a unique mechanism of action by enhancing the https://tesslxgw901325.mpeblog.com/69886362/novel-glp-1-and-gip-receptor-agonists-a-new-frontier-in-diabetes-treatment